Hiva Kolodrubetz, NP, provides an engaging and detailed session on anti-diabetic medications, focusing on safe prescribing and effective management strategies. Highlighting pharmacological mechanisms, A1C goals, and patient-centered care,…
Associate Professor Mike Todorovic, AKA “Dr. Mike”, introduces the endocrine system, explaining how hormones act as chemical messengers released into the bloodstream by cells, tissues, and glands. He…
NEW YORK (Reuters Health) – Coronary angiography is a recommended screening test for many patients undergoing kidney transplantation and now new research shows that it can be performed…
NEW YORK (Reuters Health) – Sildenafil (Viagra) is associated with a number of side effects, but data on long-term harms are still lacking, a systematic review and meta-analysis…
NEW YORK (Reuters Health) – In non-diabetic patients with hypertensive kidney disease, the risk of hyperkalemia with angiotensin converting enzyme (ACE) inhibitors is “small,” according to research reported…
NEW YORK (Reuters Health) – Treatment of mild gestational diabetes mellitus (GDM) cut the risks of fetal overgrowth, shoulder dystocia, cesarean delivery, and hypertensive disorders in a study…
NEW YORK (Reuters Health) – Women who become mothers are more likely to develop the metabolic syndrome during middle age than are their nulliparous counterparts, prospective study findings…
NEW YORK (Reuters Health) – Diabetes is an independent risk factor for atrial fibrillation in women, U.S. investigators report in the October issue of Diabetes Care. The disease…
NEW YORK (Reuters Health) – In older patients with stable coronary disease, adding percutaneous coronary intervention (PCI) to optimal medical therapy neither improves nor worsens their outcomes, new…
NEW YORK (Reuters Health) – Excessive intake of fructose can increase blood pressure and induce other features of the metabolic syndrome, according to study findings presented Wednesday at…
NEW YORK (Reuters Health) – Amlodipine-based therapy is still a better treatment for uncomplicated hypertension than atenolol-based therapy, even in patients with higher baseline heart rates, according to…
NEW YORK (Reuters Health) – Darusentan, a selective endothelin-receptor blocker, can reduce blood pressure in patients who have not reached their target levels using three or more antihypertensive…
